Genpact

GNYSEUSD

THESIS ALERT

Email me when the G thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$43.60
+$0.53 (+1.23%)Today 1M +25.20%
After hours$43.600.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$43.07
Prior regular-session close from the quote source.
$42.41–$43.65
Regular-session low and high so far today.
2.2M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$26.85–$48.64
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own G if its process-domain expertise and large global delivery base make AI-enabled operations a higher-value transformation business rather than a commoditized labor-arbitrage outsourcer.

G price history

Latest price$43.60Today+$0.53 (+1.23%)
G +26.62%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Enterprise clients continue choosing Genpact because its process intelligence, domain knowledge, and last-mile execution lower transformation risk versus building captive shared-service centers or using generic IT outsourcers.StrengtheningMateriality: High

    GAAP annual revenue rose from $4.371 billion in FY2022 to $5.080 billion in FY2025. If this holds, revenue growth can remain tied to durable workflow relationships rather than cyclical project spend; if it breaks, Genpact becomes easier to replace and growth quality deteriorates.

    Watch: Large enterprise clients move finance, procurement, customer operations, or analytics workflows back into captive shared-service centers after deploying internal AI automation.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue rose from $4.371 billion in FY2022 to $5.080 billion in FY2025.

    Open source ↗
  • Genpact’s domain-specific, technology-enabled delivery remains differentiated enough to avoid pure labor-arbitrage pricing and protect gross profitability despite automation and wage pressure.StrengtheningMateriality: High

    GAAP annual gross profit increased from $1.536 billion in FY2022 to $1.831 billion in FY2025. If the claim holds, growth can create value; if pricing becomes commoditized, revenue growth would come at a lower gross-profit dollar contribution.

    Watch: Clients force Genpact to pass through most AI productivity benefits through lower unit prices or outcome-based contracts.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit increased from $1.536 billion in FY2022 to $1.831 billion in FY2025.

    Open source ↗
  • Genpact’s scale and automation investments convert incremental revenue into operating leverage rather than requiring proportional headcount and overhead growth.StrengtheningMateriality: Medium

    GAAP annual operating income increased from $502 million in FY2022 to $750 million in FY2025. If operating leverage persists, earnings can grow faster than revenue; if not, the AI transition becomes a cost center rather than a margin driver.

    Watch: Genpact must materially increase AI platform, consulting, or sales investment without corresponding automation savings.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income increased from $502 million in FY2022 to $750 million in FY2025.

    Open source ↗
  • Because Genpact operates embedded enterprise workflows rather than capital-heavy infrastructure, the business remains capable of converting earnings into cash while growing.StrengtheningMateriality: Medium

    GAAP annual operating cash flow rose from $444 million in FY2022 to $813 million in FY2025. Cash conversion funds reinvestment, acquisitions, dividends, buybacks, or balance-sheet flexibility; weak cash conversion would make accounting earnings less valuable.

    Watch: Large clients stretch payment terms or demand financing as part of transformation contracts.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow rose from $444 million in FY2022 to $813 million in FY2025.

    Open source ↗
  • The AI and process-transformation strategy improves per-share value only if EPS gains come from recurring operating performance rather than temporary tax, FX, or below-the-line factors.HoldingMateriality: Medium

    GAAP diluted EPS improved from $1.88 in FY2022 to $3.13 in FY2025. Owners need durable per-share compounding, not just revenue expansion or one-year accounting rebounds.

    Watch: Future EPS growth is driven mainly by tax-rate changes, FX, or non-operating gains rather than operating income growth.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP diluted EPS improved from $1.88 in FY2022 to $3.13 in FY2025.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Enterprise clients continue choosing Genpact because its process intelligence, domain knowledge, and last-mile execution lower transformation risk versus building captive shared-service centers or using generic IT outsourcers. If this holds, revenue growth can remain tied to durable workflow relationships rather than cyclical project spend; if it breaks, Genpact becomes easier to replace and growth quality deteriorates.

Genpact’s domain-specific, technology-enabled delivery remains differentiated enough to avoid pure labor-arbitrage pricing and protect gross profitability despite automation and wage pressure. If the claim holds, growth can create value; if pricing becomes commoditized, revenue growth would come at a lower gross-profit dollar contribution.

Genpact’s scale and automation investments convert incremental revenue into operating leverage rather than requiring proportional headcount and overhead growth. If operating leverage persists, earnings can grow faster than revenue; if not, the AI transition becomes a cost center rather than a margin driver.

Because Genpact operates embedded enterprise workflows rather than capital-heavy infrastructure, the business remains capable of converting earnings into cash while growing. Cash conversion funds reinvestment, acquisitions, dividends, buybacks, or balance-sheet flexibility; weak cash conversion would make accounting earnings less valuable.

The AI and process-transformation strategy improves per-share value only if EPS gains come from recurring operating performance rather than temporary tax, FX, or below-the-line factors. Owners need durable per-share compounding, not just revenue expansion or one-year accounting rebounds.

All standing thesis claims
Original report summary

its process-domain expertise and large global delivery base make AI-enabled operations a higher-value transformation business rather than a commoditized labor-arbitrage outsourcer.

Evidence assessed Oct 15, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Genpact

Where the evidence on Genpact stands: Holding on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.

Bull case: what the evidence supports

  • Enterprise clients continue choosing Genpact because its process intelligence, domain knowledge, and last-mile execution lower transformation risk versus building captive shared-service centers or using generic IT outsourcers.

    sec.gov ↗

  • Genpact’s domain-specific, technology-enabled delivery remains differentiated enough to avoid pure labor-arbitrage pricing and protect gross profitability despite automation and wage pressure.

    sec.gov ↗

  • Genpact’s scale and automation investments convert incremental revenue into operating leverage rather than requiring proportional headcount and overhead growth.

    sec.gov ↗

  • Because Genpact operates embedded enterprise workflows rather than capital-heavy infrastructure, the business remains capable of converting earnings into cash while growing.

    sec.gov ↗

  • The AI and process-transformation strategy improves per-share value only if EPS gains come from recurring operating performance rather than temporary tax, FX, or below-the-line factors.

    sec.gov ↗

Bear case: what would count against it

  • Large enterprise clients move finance, procurement, customer operations, or analytics workflows back into captive shared-service centers after deploying internal AI automation.

    sec.gov ↗

  • Clients force Genpact to pass through most AI productivity benefits through lower unit prices or outcome-based contracts.

    sec.gov ↗

  • Genpact must materially increase AI platform, consulting, or sales investment without corresponding automation savings.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Genpact

Loading the break-condition record for Genpact.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Director or principal officer change.

    Genpact filed an SEC 8-K on 2026-09-08: Director or principal officer change. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Genpact filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Genpact filed an SEC 8-K on 2026-05-07: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large enterprise clients move finance, procurement, customer operations, or analytics workflows back into captive shared-service centers after deploying internal AI automation.
  • Clients force Genpact to pass through most AI productivity benefits through lower unit prices or outcome-based contracts.
  • Genpact must materially increase AI platform, consulting, or sales investment without corresponding automation savings.
  • Large clients stretch payment terms or demand financing as part of transformation contracts.
  • Future EPS growth is driven mainly by tax-rate changes, FX, or non-operating gains rather than operating income growth.

G news

Loading headlines…

Financial statements

G income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

G: quick answers

Have members of Congress traded G?
Reports made public in the last 90 days disclose 1 trade in G by 1 filer: 0 purchases and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed G trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.